Went on FDA510k search and cannot find SleepcheckRX or Resapp. As their system only updated to 1 July, these two anns must be only released and not held up.
Not sure if ASIC will care about the price sensitive ann after IER valuation date, I will email ASIC to see how they respond to this.
- Forums
- ASX - By Stock
- RAP
- Ann: Medgate extends licence agreement and plans to expand use
Ann: Medgate extends licence agreement and plans to expand use, page-43
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)